Libido
PT-141
A peptide for sexual desire and response that works by activating specific receptors in the nervous system. It helps boost sexual desire in some people, and differs from treatments that rely mainly on increasing blood flow to the organs. Its effects have been studied in cases of low sexual desire in men and women, and in helping them treat dysfunction.
- Tested by the independent Janoshik lab
- Lyophilised
- A real person answers on WhatsApp
More information
We'll answer all your questions on WhatsApp.
2019FDA approval of Vyleesi
1,267Women in two phase 3 trials
24Weeks per trial
RECONNECT trials, 24 weeks, in premenopausal women with low sexual desire.
Part of a stack
Similar peptides